Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.61 |
| ▸ | ABL1 | P00519 | 1/20 | 0.59 |
| ▸ | BCR | P11274 | 1/20 | 0.59 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.53 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21114347 | 1.00 | XDH (0.67) | XDHCYP3A4CYP2B6CYP1A2CYP2D6 | |
| SCHEMBL197271 | 1.00 | XDH (0.67) | XDHCYP3A4CYP2B6CYP1A2CYP2D6 | |
| Syringaldehyde SCHEMBL4576470 | 0.95 | XDH (0.61) | XDHCYP3A4CYP2B6CYP1A2CYP2D6 | |
| Syringaldehyde SCHEMBL4576467 | 0.95 | XDH (0.61) | XDHCYP3A4CYP2B6CYP1A2CYP2D6 | |
| SCHEMBL13176649 | 0.93 | XDH (0.68) | XDHCYP3A4CYP2B6CYP1A2CYP2D6 | |
| SCHEMBL151754 | 0.93 | XDH (0.68) | XDHCYP3A4CYP2B6CYP1A2CYP2D6 | |
| SCHEMBL19473601 | 0.90 | XDH (0.59) | XDHCYP3A4CYP2B6CYP1A2CYP2D6 | |
| SCHEMBL8817683 | 0.88 | ABL1 (0.68) | XDHCYP3A4CYP2B6CYP1A2CYP2D6 | |
| SCHEMBL17843663 | 0.83 | ABL1 (0.80) | CYP3A4CYP2B6CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL16372856 | 0.83 | ABL1 (0.80) | CYP3A4CYP2B6CYP1A2CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 847 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4659830-A2 | EFFICIENT DEPOLYMERIZATION METHOD OF POLYMER COMPRISING ESTER FUNCTIONAL GROUP, AND PURIFICATION METHOD THEREOF | Korea Research Institute of Chemical Technology (KR) | 2025-12-10 | — | — | EP | claimed |
| US-20250066702-A1 | BEVERAGE CONTAINING STEVIOL GLYCOSIDE | SUNTORY HOLDINGS LIMITED (JP) | 2025-02-27 | — | — | US | claimed |
| US-12234384-B2 | Adhesion-improving composition for textile material and associated reinforcing textile material | PORCHER INDUSTRIES (FR) | 2025-02-25 | — | — | US | claimed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| EP-4458937-A1 | BEVERAGE CONTAINING STEVIOL GLYCOSIDE | Suntory Holdings Limited (JP) | 2024-11-06 | — | — | EP | claimed |
| CN-118130638-A | Fingerprint quality control method for non-volatile components of detumescence and analgesic composition | 广西壮族自治区花红药业集团股份公司 | 2024-06-04 | — | — | CN | claimed |
| EP-4317280-A1 | EXTRACTANT AND EXTRACTION METHOD FOR REMOVING COLOR-EXPRESSING FOREIGN SUBSTANCES FROM COLORED POLYMER CONTAINING ESTER FUNCTIONAL GROUP, AND METHOD FOR CHEMICALLY SELECTING POLYMER CONTAINING ESTER FUNCTIONAL GROUP FROM COLORED POLYMER MIXTURE | Korea Research Institute of Chemical Technology (KR) | 2024-02-07 | — | — | EP | claimed |
| US-11781061-B2 | Corrosion protection method for wellbore piping | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-10-10 | — | — | US | claimed |
| US-20230312451-A1 | EFFICIENT DEPOLYMERIZATION METHOD OF POLYMERS COMPRISING ESTER FUNCTIONAL GROUP, AND PURIFICATION METHOD THEREOF | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-10-05 | — | — | US | claimed |
| CN-116687962-A | Composition for preventing or treating diabetes and application thereof | 青岛大学 | 2023-09-05 | — | — | CN | claimed |
| US-6485529-B1 | Agent and method for coloring fibers | WELLA AKTIENGESELLSCHAFT (DE) | 2002-11-26 | — | — | US | claimed |
| JP-2002540060-A | — | — | 2002-11-26 | — | — | JP | claimed |
| CN-1367693-A | Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors and method of using the same | GUILFORD PHARM INC (US) | 2002-09-04 | — | — | CN | claimed |
| WO-2002033404-A2 | INTEGRATED WINE QUALITY SENSOR | TRAUNER KENNETH B (US) | 2002-04-25 | — | — | WO | claimed |
| EP-1171130-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING POLY(ADP-RIBOSE) GLYCOHYDROLASE INHIBITORS AND METHODS OF USING THE SAME | GUILFORD PHARMACEUTICALS INC. (US) | 2002-01-16 | — | — | EP | claimed |
| EP-0785190-B1 | Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK & CHEMICALS (JP) | 2000-08-16 | — | — | EP | claimed |
| WO-2000025787-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING POLY(ADP-RIBOSE) GLYCOHYDROLASE INHIBITORS AND METHODS OF USING THE SAME | GUILFORD PHARMACEUTICALS INC. (US) | 2000-05-11 | — | — | WO | claimed |
| US-5942521-A | Quinolinone derivative and anti-allergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1999-08-24 | — | — | US | claimed |
| CN-1163268-A | Quinolinone derivatives and antiallergic agent containing said quinolinone derivatives as active ingredient | LAINIPPON INK AND CHEMICALC IN (JP) | 1997-10-29 | — | — | CN | claimed |
| EP-0785190-A2 | Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1997-07-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312451-A1 | EFFICIENT DEPOLYMERIZATION METHOD OF POLYMERS COMPRISING ESTER FUNCTIONAL GROUP, AND PURIFICATION METHOD THEREOF | ALG1, TYR, ACP1 | XDH 3574/4885CYP3A4 1750/4885CYP2B6 2751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.